Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alberti

Showing results (511-520 of 613) with videos related to

Pageof 62
Sort By:
The Journal of Clinical Investigation|June 1, 1993
A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humansM L Hartman, P E Clayton, M L Johnson, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart diseaseR A Wright, A M Perrie, F Stenhouse, et al.
Diabete & Metabolisme|September 1, 1982
Opiate receptors and the metabolic response to intravenous glucoseR D Leslie, C Eff, A H Barnett, et al.
Clinical Endocrinology|December 1, 1986
Effects of somatostatin analogue SMS 201-995 in non-insulin-dependent diabetesR R Davies, M Miller, S J Turner, et al.
Lancet (London, England)|January 31, 1976
Failure of somatostatin to correct manifest diabetic ketoacidosisK Lundbaek, A P Hansen, H Orskov, et al.
Clinical Endocrinology|July 1, 1983
Evidence that thyroid hormones regulate gluconeogenesis from glycerol in manA J McCulloch, D G Johnston, P H Baylis, et al.
Diabetes Research and Clinical Practice|February 1, 1992
The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance testC S Yajnik, K M Shelgikar, S S Naik, et al.
Minerva Cardioangiologica|September 1, 1996
[Introduction of definite molecular weight heparan sulfate in a protocol of prevention of deep venous thrombosis in prosthetic orthopedic surgery]M Mandò, G P Margiacchi, R Alioto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitusS N Davis, M Ansiferov, C Hetherington, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolismH Nørrelund, N Vahl, A Juul, et al.
Pageof 62

Showing results (511-520 of 613) with videos related to

Sort By:
Pageof 62
The Journal of Clinical Investigation|June 1, 1993
A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humansM L Hartman, P E Clayton, M L Johnson, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart diseaseR A Wright, A M Perrie, F Stenhouse, et al.
Diabete & Metabolisme|September 1, 1982
Opiate receptors and the metabolic response to intravenous glucoseR D Leslie, C Eff, A H Barnett, et al.
Clinical Endocrinology|December 1, 1986
Effects of somatostatin analogue SMS 201-995 in non-insulin-dependent diabetesR R Davies, M Miller, S J Turner, et al.
Lancet (London, England)|January 31, 1976
Failure of somatostatin to correct manifest diabetic ketoacidosisK Lundbaek, A P Hansen, H Orskov, et al.
Clinical Endocrinology|July 1, 1983
Evidence that thyroid hormones regulate gluconeogenesis from glycerol in manA J McCulloch, D G Johnston, P H Baylis, et al.
Diabetes Research and Clinical Practice|February 1, 1992
The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance testC S Yajnik, K M Shelgikar, S S Naik, et al.
Minerva Cardioangiologica|September 1, 1996
[Introduction of definite molecular weight heparan sulfate in a protocol of prevention of deep venous thrombosis in prosthetic orthopedic surgery]M Mandò, G P Margiacchi, R Alioto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitusS N Davis, M Ansiferov, C Hetherington, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolismH Nørrelund, N Vahl, A Juul, et al.
Pageof 62